End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.085 CAD | -10.53% | -5.56% | -15.00% |
Apr. 01 | Willow Biosciences Narrows 2023 Loss YOY | MT |
Mar. 29 | Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 821K 600K | Sales 2023 | 1.17M 857K | Capitalization | 12.42M 9.08M |
---|---|---|---|---|---|
Net income 2022 | -14M -10.23M | Net income 2023 | -13M -9.5M | EV / Sales 2022 | -0.95 x |
Net cash position 2022 | 15.01M 10.97M | Net cash position 2023 | 1.63M 1.19M | EV / Sales 2023 | 9.21 x |
P/E ratio 2022 |
-0.96
x | P/E ratio 2023 |
-0.95
x | Employees | 19 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.66% |
1 day | -10.53% | ||
1 week | -5.56% | ||
Current month | -10.53% | ||
1 month | -10.53% | ||
3 months | -22.73% | ||
6 months | +6.25% | ||
Current year | -15.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Savile
CEO | Chief Executive Officer | - | 19-04-11 |
Travis Doupe
DFI | Director of Finance/CFO | - | 19-04-11 |
Trish Choudhary
CTO | Chief Tech/Sci/R&D Officer | - | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Lalonde
CHM | Chairman | 63 | 23-02-20 |
Donald Archibald
BRD | Director/Board Member | 63 | 19-04-11 |
Director/Board Member | 51 | 19-04-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.085 | -10.53% | 4,000 |
24-05-01 | 0.095 | 0.00% | 24,500 |
24-04-30 | 0.095 | +5.56% | 81,000 |
24-04-29 | 0.09 | 0.00% | 12,950 |
End-of-day quote Toronto S.E., May 02, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-15.00% | 7.9M | |
-3.89% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+53.49% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+6.52% | 8.81B |
- Stock Market
- Equities
- WLLW Stock